Vitality Watch

Dossier pubmed preclinical 30-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.

Key claim: Cannabigerol combined with resistance exercise markedly improved muscle power output, peak grip strength, and lactate clearance in mice with glucocorticoid-induced muscle atrophy.

Abstract

Sarcopenia is a major clinical condition associated with aging and is characterized by progressive loss of skeletal muscle mass and function. Resistance training is an effective intervention to counteract muscle atrophy; however, strategies that selectively enhance functional performance remain limited. Cannabigerol, a phytocannabinoid that is not a CB1 receptor agonist and therefore lacks psychotomimetic activity, has emerged as a potential modulator of neuromuscular function, although its role in skeletal muscle adaptation remains poorly understood. Here, we investigated the effects of resistance exercise and cannabigerol, alone and in combination, in a dexamethasone-induced model of muscle atrophy in mice. Animals received dexamethasone (20 mg/kg, i.p.) for 12 days and were subsequently subjected to a 4-week ladder-based resistance exercise protocol. Cannabigerol (10 mg/kg, i.p.) was administered on training days. Resistance exercise restored muscle morphology and improved fatigue resistance. In contrast, cannabigerol acted mainly on neuromuscular performance, increasing muscle power while producing only a small increase in fiber cross-sectional area. Cannabigerol potentiated training-induced power output, increasing performance by ∼55% in the first week and up to ∼87% after 4 weeks compared to exercise alone. In addition, cannabigerol increased peak grip strength (∼10%) and lowered post-exercise blood lactate in sedentary animals (∼48%). These findings show that resistance exercise and cannabigerol exert complementary effects on skeletal muscleexercise promoting structural recovery and cannabigerol enhancing neuromuscular performance and lowering post-exercise lactateand support further investigation of cannabigerol as an adjunct to exercise in glucocorticoid-induced muscle atrophy.

Why this matters

[animal-model] This study extends exercise-adjunct research to cannabigerol, with functional and metabolic improvements reported in mice with glucocorticoid-induced muscle atrophy. [animal-model] The findings do not establish benefits in human aging or age-related sarcopenia, and the supplied results do not resolve whether the combination produces a genuinely synergistic effect.

Source

Link

Briefing card

Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.
Stage: preclinical · pubmed · 30-sep-2026

If you take CBG for muscle performance, this mouse study does not establish that it improves strength or exercise performance in humans.

Cannabigerol combined with resistance exercise markedly improved muscle power output, peak grip strength, and lactate clearance in mice with glucocorticoid-induced muscle atrophy.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1021/acsptsci.6c00187

build build 880 · 2bcef25 · 2026-11-18